# Betamethasone and Closure of Ductus Arteriosus

> **NCT05987202** · — · UNKNOWN · sponsor: **Hospices Civils de Lyon** · enrollment: 51 (estimated)

## Conditions studied

- Persistent Ductus Arteriosus

## Interventions

- **OTHER:** DA closure in a population of premature infants

## Key facts

- **NCT ID:** NCT05987202
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05987202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05987202, "Betamethasone and Closure of Ductus Arteriosus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05987202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*